T Dörner and P E Lipsky

Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus
Lupus 2004 13: 283-289. [Abstract] [PDF] [References]  

J D Reveille

Predictive value of autoantibodies for activity of systemic lupus erythematosus
Lupus 2004 13: 290-297. [Abstract] [PDF] [References]  

S Manzi, J M Ahearn, and J Salmon

New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus
Lupus 2004 13: 298-303. [Abstract] [PDF] [References]  

P J Utz

Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus
Lupus 2004 13: 304-311. [Abstract] [PDF] [References]  

C Gorman, M Leandro, and D Isenberg

Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
Lupus 2004 13: 312-316. [Abstract] [PDF] [References]  

W Stohl

A therapeutic role for BLyS antagonists
Lupus 2004 13: 317-322. [Abstract] [PDF] [References]  

D J Wallace and J A Tumlin

LJP 394 (abetimus sodium, Riquent) in the management of systemic lupus erythematosus
Lupus 2004 13: 323-327. [Abstract] [PDF] [References]  

R P Rother, C F Mojcik, and E W McCroskery

Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus
Lupus 2004 13: 328-334. [Abstract] [PDF] [References]  

J T Merrill

LJP 1082: a toleragen for Hughes syndrome
Lupus 2004 13: 335-338. [Abstract] [PDF] [References]  

E Tackey, P E Lipsky, and G G Illei

Rationale for interleukin-6 blockade in systemic lupus erythematosus
Lupus 2004 13: 339-343. [Abstract] [PDF] [References]  

M Aringer and J S Smolen

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention
Lupus 2004 13: 344-347. [Abstract] [PDF] [References]  

K N Schmidt and W Ouyang

Targeting interferon-: a promising approach for systemic lupus erythematosus therapy
Lupus 2004 13: 348-352. [Abstract] [PDF] [References]  

V C Kyttaris, Y-T Juang, and G C Tsokos

Gene therapy in systemic lupus erythematosus
Lupus 2004 13: 353-358. [Abstract] [PDF] [References]  

D Jayne and A Tyndall

Autologous stem cell transplantation for systemic lupus erythematosus
Lupus 2004 13: 359-365. [Abstract] [PDF] [References]  

M Petri

Cyclophosphamide: new approaches for systemic lupus erythematosus
Lupus 2004 13: 366-371. [Abstract] [PDF] [References]  

M Dall’Era and J Davis

CTLA4Ig: a novel inhibitor of costimulation
Lupus 2004 13: 372-376. [Abstract] [PDF] [References]  

J Yazdany and J Davis

The role of CD40 ligand in systemic lupus erythematosus
Lupus 2004 13: 377-380. [Abstract] [PDF] [References]  

R J Looney, J Anolik, and I Sanz

B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells
Lupus 2004 13: 381-390. [Abstract] [PDF] [References]  

P I Sidiropoulos and D T Boumpas

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Lupus 2004 13: 391-397. [Abstract] [PDF] [References]  

J Schiffenbauer and L S Simon

Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
Lupus 2004 13: 398-405. [Abstract] [PDF] [References]  

V Strand

Clinical trial design in systemic lupus erythematosus: lessons learned and future directions
Lupus 2004 13: 406-411. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.